Shanghai Pharma Eyes Acquisitions In The U.S., Europe
This article was originally published in PharmAsia News
Executive Summary
Shanghai Pharmaceutical Holdings Co. Ltd. plans to establish a base overseas through acquisitions targeting midsize drug makers in Europe and the U.S. within the next six to12 months, said Ge Jianqiu, the distributor's vice president, at a performance announcement conference